CAM
BEAT

Capstone Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Capstone Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$620K Sell
18,550
-440
-2% -$13.1K 0.02% 785
2017
Q1 		$550K Sell
18,990
-920
-5% -$22.8K 0.02% 848
2016
Q4 		$445K Buy
19,910
+1,610
+9% +$31.5K 0.01% 1020
2016
Q3 		$340K Buy
+18,300
New +$345K 0.01% 1230

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Capstone Asset Management's BEAT Position: Q2 2017 in Review

Capstone Asset Management reduced its BioTelemetry, Inc. (BEAT) stake by 2.3% in Q2 2017, selling an estimated $13.1K and leaving 18,550 shares worth $620K. The position accounts for 0.02% of the portfolio, ranked #785.

Capstone Asset Management first reported a position in BEAT in Q3 2016 and has held it in 4 quarters since. 195 funds tracked by Wall St. Rank hold BEAT as of Q2 2017.

  • Capstone Asset Management held 18,550 shares of BioTelemetry, Inc. worth $620K as of Q2 2017.
  • Capstone Asset Management sold 440 BioTelemetry, Inc. shares in Q2 2017, an estimated $13.1K.
  • BioTelemetry, Inc. made up 0.02% of Capstone Asset Management's portfolio in Q2 2017, its #785 holding.
  • Capstone Asset Management first reported a position in BioTelemetry, Inc. in Q3 2016 and has held it in 4 quarters since.
  • 195 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.